Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Pictured: Diane Reidy
Feature
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, February 19, 2014

Cycle for Survival, Memorial Sloan Kettering’s nationwide indoor team cycling event, helps support research into rare cancers. Three researchers discuss how these funds benefit their research.

Pictured: Vivian Tabar
Profile
By Celia Gittelson, BA  |  Monday, February 17, 2014

Viviane Tabar performs complex surgeries for patients with brain tumors and, outside the operating room, focuses on the relationship between stem cells and brain cancers.

Finding
By Jenifer Goodwin, Freelance Writer  |  Thursday, February 6, 2014

Investigators have found a possible molecular explanation for why obese people with kidney cancer tend to fare better despite having a higher rate of diagnosis.

Pictured: Stephen Solomon
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, January 27, 2014

Irreversible electroporation – a new, minimally invasive treatment that uses electric current to poke tiny holes in cell membranes – is showing promise against hard-to-treat tumors.

Pictured: Simon Powell
Profile
By Celia Gittelson, BA  |  Friday, January 24, 2014

Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.

Research
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, January 22, 2014

Obesity in patients with early-stage tongue cancer has been linked to a five-fold increase in the risk of death.

Pictured: Alice Ho
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, January 20, 2014

A new approach for treating breast cancer spreads radiation doses over a larger number of beams, providing more thorough coverage.

Pictured: Nai-Kong Cheung & Jeremy D
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Thursday, January 9, 2014

Common genetic alterations in neuroblastoma tumors may help doctors predict the likelihood the cancer will spread to the brain.

Pictured: Jedd Wolchok & Alexander Rudensky
Announcement
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 6, 2014

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.

Pictured: Stem cell-derived nerve cells exposed to progerin
In the Lab
By Jennifer Bell, PhD  |  Monday, December 30, 2013

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.

Pictured: Low-dose CT scans
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: T cells
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 23, 2013

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

In Memoriam
By Craig Thompson, MD, President and CEO  |  Friday, December 20, 2013

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.

Pictured: Alexander Rudensky
Profile
By Celia Gittelson, BA  |  Monday, December 16, 2013

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

Center News

Stay Informed

Get the latest information about cancer care and research every month.